Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.
Related Posts
What we know about the apparent Trump shooting attempt
The suspect, Ryan Wesley Routh, remains in custody and has been charged with firearm offences.
Japan’s bond market raises alarm over risks of outflows from U.S., carry trade unwind and market turmoil
Higher Japan government bond yields could spark a wave of capital repatriation with Japanese investors pulling funds from the U.S.
How the UK plans to prevent another Liz Truss ‘mini-budget’ crisis — which triggered huge bond sell-off
A new bill would prevent “significant uncosted measures” from being announced without an analysis of their impact on public finances.